1. Home
  2. ARQT vs KN Comparison

ARQT vs KN Comparison

Compare ARQT & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • KN
  • Stock Information
  • Founded
  • ARQT 2016
  • KN 1946
  • Country
  • ARQT United States
  • KN United States
  • Employees
  • ARQT N/A
  • KN N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • KN Consumer Electronics/Appliances
  • Sector
  • ARQT Health Care
  • KN Consumer Staples
  • Exchange
  • ARQT Nasdaq
  • KN Nasdaq
  • Market Cap
  • ARQT 2.1B
  • KN 1.8B
  • IPO Year
  • ARQT 2020
  • KN N/A
  • Fundamental
  • Price
  • ARQT $16.93
  • KN $22.20
  • Analyst Decision
  • ARQT Strong Buy
  • KN Buy
  • Analyst Count
  • ARQT 7
  • KN 3
  • Target Price
  • ARQT $19.00
  • KN $21.00
  • AVG Volume (30 Days)
  • ARQT 1.5M
  • KN 500.7K
  • Earning Date
  • ARQT 11-05-2025
  • KN 10-23-2025
  • Dividend Yield
  • ARQT N/A
  • KN N/A
  • EPS Growth
  • ARQT N/A
  • KN N/A
  • EPS
  • ARQT N/A
  • KN 0.28
  • Revenue
  • ARQT $263,464,999.00
  • KN $563,100,000.00
  • Revenue This Year
  • ARQT $72.46
  • KN $8.20
  • Revenue Next Year
  • ARQT $32.00
  • KN $5.13
  • P/E Ratio
  • ARQT N/A
  • KN $80.81
  • Revenue Growth
  • ARQT 99.50
  • KN 9.17
  • 52 Week Low
  • ARQT $8.03
  • KN $12.19
  • 52 Week High
  • ARQT $18.15
  • KN $22.65
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 57.20
  • KN 66.07
  • Support Level
  • ARQT $15.13
  • KN $21.08
  • Resistance Level
  • ARQT $18.15
  • KN $21.98
  • Average True Range (ATR)
  • ARQT 0.67
  • KN 0.44
  • MACD
  • ARQT 0.08
  • KN 0.02
  • Stochastic Oscillator
  • ARQT 60.00
  • KN 77.04

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in three segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions, Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications and the Consumer MEMS Microphones segment designs and manufactures micro-electro-mechanical systems microphones and audio solutions used in applications. The majority of its revenue comes from the Consumer MEMS Microphones segment.

Share on Social Networks: